Abstract:Dentin sialophosphoprotein (DSPP) is an extracellular matrix protein that is highly expressed in odontoblasts, but only transiently expressed in presecretory ameloblasts during tooth development. We previously generated a knockin mouse model expressing a mouse equivalent (DSPP, p.P19L) of human mutant DSPP (p.P17L; referred to as “ Dspp P19L/+ ”), and reported that Dspp P19L/+ and Dspp P19L/P19L mice manifested a dentin phenotype resembling human dentinogenesis imperfecta (DGI). In this study, we analyzed pathogenic effects of mutant P19L-DSPP on enamel development in Dspp P19L/+ and Dspp P19L/P19L mice. Micro-Computed Tomography (μCT) analyses of 7-week-old mouse mandibular incisors showed that Dspp P19L/P19L mice had significantly decreased enamel volume and/or enamel density at different stages of amelogenesis examined. Acid-etched scanning electron microscopy (SEM) analyses of mouse incisors demonstrated that, at the mid-late maturation stage of amelogenesis, the enamel of wild-type mice already had apparent decussating pattern of enamel rods, whereas only minute particulates were found in Dspp P19L/+ mice, and no discernible structures in Dspp P19L/P19L mouse enamel. However, by the time that incisor enamel was about to erupt into oral cavity, distinct decussating enamel rods were evident in Dspp P19L/+ mice, but only poorly-defined enamel rods were revealed in Dspp P19L/P19L mice. Moreover, μCT analyses of the mandibular first molars showed that Dspp P19L/+ and Dspp P19L/P19L mice had a significant reduction in enamel volume and enamel density at the ages of 2, 3, and 24weeks after birth. Backscattered and acid-etched SEM analyses revealed that while 3-week-old Dspp P19L/+ mice had similar pattern of enamel rods in the mandibular first molars as age-matched wild-type mice, no distinct enamel rods were observed in Dspp P19L/P19L mice. Yet neither Dspp P19L/+ nor Dspp P19L/P19L mice showed well-defined enamel rods in the mandibular first molars by the age of 24weeks, as judged by backscattered and acid-etched SEM. In situ hybridization showed that DSPP mRNA level was markedly reduced in the presecretory ameloblasts, but immunohistochemistry revealed that DSP/DSPP immunostaining signals were much stronger within the presecretory ameloblasts in Dspp mutant mice than in wild-type mice. These results suggest that mutant P19L-DSPP protein caused developmental enamel defects in mice, which may be associated with intracellular retention of mutant DSPP in the presecretory ameloblasts.

Mechanisms of disease: what can mouse models tell us about the molecular processes underlying Dent disease?

A novel transgenic mouse model highlights molecular disruptions involved in the pathogenesis of Dent disease 1

The ClC-5 chloride channel knock-out mouse - an animal model for Dent's disease

Dent disease 1-linked novel CLCN5 mutations result in aberrant location and reduced ion currents

Dentoalveolar Alterations in an Adenine‐Induced Chronic Kidney Disease Mouse Model

4-Phenylbutyric Acid Treatment Reduces Low-Molecular-Weight Proteinuria in a Clcn5 Knock-in Mouse Model for Dent Disease-1

Dent Disease: Classification, Heterogeneity and Diagnosis

Genetic Analysis of Dent's Disease and Functional Research of CLCN5 Mutations

Mutation Update of the CLCN5 Gene Responsible for Dent Disease 1

Current knowledge of tooth development: patterning and mineralization of the murine dentition

Accelerated enamel mineralization in Dspp mutant mice

Changes in the composition and mechanical properties of dentin in mouse models of diabetes

Enamel Defects Associated With Dentin Sialophosphoprotein Mutation in Mice

Mouse Dspp frameshift model of human dentinogenesis imperfecta

Dent disease in childhood and associated clinical problems

Modelling diabetic nephropathy in mice

Kidney Disease Models: Tools to Identify Mechanisms and Potential Therapeutic Targets

Fluoride Alters Signaling Pathways Associated with the Initiation of Dentin Mineralization in Enamel Fluorosis Susceptible Mice

Research Models in Dentine Development and Regeneration

Gene therapy of Dent disease type 1 in newborn ClC-5 null mice for sustained transgene expression and gene therapy effects

Molecular Simulations Meet Personalized Medicine. The Mechanism of Action of ClC-5 Antiporter and the Origin of Dent's Disease